// App-Quantinova.ai

: Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

Researchers

Presenter

  • Andrew Menzies-Gow

Principal Investigators

  • Jonathan Corren

  • Arnaud Bourdin

  • Geoffrey Chupp

  • Elliot Israel

  • Janet Griffiths

  • sa Hellqvist

  • Karin Bowen

  • Primal Kaur

  • Gun Almqvist

  • Sandhia Ponnarambil

  • Gene Colice

Medical Centers

  • Royal Brompton Hospital, London, FL

  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA

  • Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France

  • Harvard Medical School, Brigham and Women's Hospital, Boston, MA.

  • Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA

  • Amgen, Thousand Oaks, CA, USA

Locations

  • United Kingdom

  • United States

  • France

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Tezepelumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved